Purinergic Signaling and Dental Orofacial Pain

Xiuxin Liu
{"title":"Purinergic Signaling and Dental Orofacial Pain","authors":"Xiuxin Liu","doi":"10.5772/intechopen.87181","DOIUrl":null,"url":null,"abstract":"Pain is a common complaint of patients in the dental clinic. Patient with dental orofacial pain usually presents with hyperalgesia and allodynia. Its management has been a challenge, especially in the status of chronic pain or neuropathic pain. Purinergic signaling is dictated by ATP release, purinergic receptors activation, and sequential hydrolysis of ATP. Purinergic signaling participates in nociception processing in the sensory nerves by control of pain signal transduction, modulation, and sensitization. Since purinergic receptors are preferentially expressed in trigeminal nerves, purinergic singling may play a crucial role in the development of dental orofacial pain. In this chapter, we overview the expressions of purinergic receptors as well as the machinery for ATP release, ATP degradations, and adenosine generation in trigeminal nerves. Specifically, the roles of ATP signaling in dental orofacial pain generation and central sensitization via activation of P2 receptors and adenosine signaling in analgesia via activation of P1 receptors in trigeminal nerves are updated. We also discuss the affection of ecto-nucleotidases, the major enzymes responsible for extracellular ATP degradation and adenosine generation in trigeminal nerves that drive the shift from ATP-induced pain to adenosine-induced analgesia. This chapter provides advanced outlines for purinergic signaling in trigeminal nerves and unveils potential therapeutic targets for the management of dental orofacial pain.","PeriodicalId":273495,"journal":{"name":"Receptors P1 and P2 as Targets for Drug Therapy in Humans","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Receptors P1 and P2 as Targets for Drug Therapy in Humans","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5772/intechopen.87181","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Pain is a common complaint of patients in the dental clinic. Patient with dental orofacial pain usually presents with hyperalgesia and allodynia. Its management has been a challenge, especially in the status of chronic pain or neuropathic pain. Purinergic signaling is dictated by ATP release, purinergic receptors activation, and sequential hydrolysis of ATP. Purinergic signaling participates in nociception processing in the sensory nerves by control of pain signal transduction, modulation, and sensitization. Since purinergic receptors are preferentially expressed in trigeminal nerves, purinergic singling may play a crucial role in the development of dental orofacial pain. In this chapter, we overview the expressions of purinergic receptors as well as the machinery for ATP release, ATP degradations, and adenosine generation in trigeminal nerves. Specifically, the roles of ATP signaling in dental orofacial pain generation and central sensitization via activation of P2 receptors and adenosine signaling in analgesia via activation of P1 receptors in trigeminal nerves are updated. We also discuss the affection of ecto-nucleotidases, the major enzymes responsible for extracellular ATP degradation and adenosine generation in trigeminal nerves that drive the shift from ATP-induced pain to adenosine-induced analgesia. This chapter provides advanced outlines for purinergic signaling in trigeminal nerves and unveils potential therapeutic targets for the management of dental orofacial pain.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
嘌呤能信号与口腔面部疼痛
疼痛是牙科诊所病人的常见主诉。口腔面部疼痛患者通常表现为痛觉过敏和异常性疼痛。其管理一直是一个挑战,特别是在慢性疼痛或神经性疼痛的状态。嘌呤能信号是由ATP释放、嘌呤能受体激活和ATP的顺序水解所决定的。嘌呤能信号通过控制疼痛信号的转导、调节和致敏参与感觉神经的痛觉加工。由于嘌呤能受体优先在三叉神经中表达,嘌呤能单化可能在口腔颌面部疼痛的发生中起关键作用。在本章中,我们概述了嘌呤能受体的表达以及三叉神经中ATP释放、ATP降解和腺苷生成的机制。具体来说,ATP信号通过激活P2受体在口腔面部疼痛产生和中枢致敏中的作用以及腺苷信号通过激活三叉神经P1受体在镇痛中的作用得到了更新。我们还讨论了外核苷酸酶的影响,外核苷酸酶是三叉神经中负责细胞外ATP降解和腺苷生成的主要酶,它推动了从ATP诱导的疼痛到腺苷诱导的镇痛的转变。本章提供了先进的概述嘌呤能信号在三叉神经和揭示潜在的治疗目标管理口腔面部疼痛。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Functions of Purinergic Receptors Purinergic Signaling and Dental Orofacial Pain The Role of Purinergic Signaling in the Pathophysiology of Perinatal Hypoxic-Ischemic Encephalopathy A Brief View of Molecular Modeling Approaches to P2 Receptors
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1